Bitterroot Bio
PrivateLast Round
Series A
Jun 7, 2023
Total Funding Raised
$145M
Company Overview
Bitterroot Bio is a biotechnology company that develops novel immunotherapies for the treatment of cardiovascular disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bitterroot Bio Comparables
Compare Bitterroot Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cardurion Pharmaceuticals | 84% | |
| POLYGON Therapeutics | 84% | |
| Cyclarity Therapeutics | 83% |
Bitterroot Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 7, 2023 |
Bitterroot Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series A |
| GV | Series A |
| ARCH Venture Partners | Series A |
| ARCH Venture Partners | Series A |
| Koch Disruptive Technologies | Series A |
| Alexandria Venture Investments | Series A |
| Koch Disruptive Technologies | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2025
Phase 1 results for BRB-002 to be presented at ACC 2025.
- Mar 17, 2025
Will present at the American College of Cardiology Annual Scientific Session 2025.
Bitterroot Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bitterroot Bio's valuation, stock price, and market status.
Is Bitterroot Bio a public or private company?
Bitterroot Bio is a private company.
What is the current stock price of Bitterroot Bio?
Bitterroot Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Bitterroot Bio worth (valuation)?
Valuation information for Bitterroot Bio is not publicly available.
Can I buy Bitterroot Bio stock?
Bitterroot Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Bitterroot Bio's last funding round?
Bitterroot Bio's most recent funding round was Series A on June 7, 2023.
Who are the main investors in Bitterroot Bio?
Key investors in Bitterroot Bio include Deerfield Management, ARCH Venture Partners.
Will Bitterroot Bio IPO soon?
No public IPO plans have been announced for Bitterroot Bio.
How can I track Bitterroot Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bitterroot Bio's secondary market activity and sign up for updates.